The report highlights a notable decline in activity due to geopolitical tensions, alongside measures taken to manage costs and maintain operational continuity. Additionally, the establishment of Klea Pharmaceuticals and the completion of a medical center in Saudi Arabia are key developments reported. The company anticipates improved profitability in the second half of the year as operations stabilize and cost management efforts take effect.
Written in English by 6ix AI from the company’s French-language filing. How 6ix writes summaries
Cette publication dispose du service " 🔒 Actusnews SECURITY MASTER ". - SECURITY MASTER Key :lZpxZ52XkmqYnZ1rZZ6ZZpeZmWtnlmeYaWeampduasqXa5yWnGxiaJSSamlhnmdn - Pour contrôler cette clé :https://www.security-master-key.com.
Information réglementée : Rapports financiers et d'audit semestriels/examens réduits :
- Rapport semestriel Euronext Growth/Euronext Access
Communiqué intégral et original au format PDF : https://www.actusnews.com/news/100921-klea_rfs-30062026vdef.pdf